Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-01

Clinical Trial Update: Oral Metronidazole With Lactobacillus Vaginal Suppositories to Prevent Recurrence of Bacterial Vaginosis [Phase 4]

View source ↗

Summary

Phase 4 trial update on oral metronidazole with Lactobacillus vaginal suppositories to prevent recurrence of bacterial vaginosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lactobacillus vaginal suppositories (Lactobacillus-containing vaginal suppositories)
  • Metronidazole (oral) (metronidazole)

Snippet

Sponsor: Peking University Shenzhen Hospital | Conditions: Bacterial Vaginosis, Recurrence | Phase 4 | Status: COMPLETED